Integer Holdings Co. (NYSE:ITGR) Shares Bought by Intech Investment Management LLC

Intech Investment Management LLC lifted its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 51.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,767 shares of the medical equipment provider's stock after buying an additional 3,980 shares during the quarter. Intech Investment Management LLC's holdings in Integer were worth $1,559,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ITGR. Mather Group LLC. boosted its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares in the last quarter. R Squared Ltd purchased a new stake in Integer during the fourth quarter worth about $44,000. Versant Capital Management Inc boosted its holdings in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after buying an additional 183 shares in the last quarter. Principal Securities Inc. grew its position in Integer by 31.2% during the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after buying an additional 152 shares during the period. Finally, Contravisory Investment Management Inc. increased its holdings in Integer by 210.8% in the fourth quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider's stock valued at $92,000 after buying an additional 470 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Remove Ads

Integer Price Performance

ITGR stock traded down $0.99 during trading on Wednesday, hitting $118.13. The stock had a trading volume of 392,200 shares, compared to its average volume of 315,919. The stock has a market cap of $3.97 billion, a price-to-earnings ratio of 35.16, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The company's 50 day moving average price is $131.84 and its two-hundred day moving average price is $132.22. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. On average, sell-side analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on ITGR shares. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. KeyCorp upped their target price on Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Truist Financial raised their price target on Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Citigroup boosted their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Finally, Benchmark raised their target price on shares of Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus price target of $149.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.